Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis - Haldar, P; Haldar, P; Brightling, C; Brightling, C; Singapuri, A; Hargadon, B; Gupta, S; Gupta, S; Monteiro, W; Bradding, P; Bradding, P; Green, R; et al. (2014)